NCT01594268已完成4 期
A Prospective, Open-label Study to Assess Safety of Certican in Kidney Transplant Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 54
- 试验地点
- 1
- 主要终点
- Number of participants with serious adverse events
研究概览
简要总结
A prospective, open label study of CERtican in KIdney transplantation
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Kidney transplantation patient
Other
Kidney transplantation patient; single arm
干预措施: Everolimus (Drug)
结局指标
主要结局
Number of participants with serious adverse events
时间窗: 12 weeks
frequency of serious adverse event
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese ParticipantsHealthy VolunteerNCT06722417AbbVie16
已完成
1 期
TINN Pharmacokinetics (PK) Study Treat Infections iN NeonatesPharmacokinetics of Ciprofloxacin in NeonatesNCT01319435Liverpool Women's NHS Foundation Trust63
已完成
2 期
A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial CancerUrinary Tract CancerNCT02006667Hoffmann-La Roche13
已完成
不适用
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular HypertensionOcular HypertensionNCT00825396Chakshu Research, Inc.12
撤回
1 期
Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular EdemaDiabetic Macular EdemaNCT02842541Eleven Biotherapeutics